Evidence map›Paper›PMID 42088748›Full record

ArticleFrontiers in pediatrics2026

Macrolide-resistant

Lulu Zheng, Huaqing Liu, Cunxin Xu, Feifei Song, Shenggang Ding

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Lulu Zheng *Department of Pediatrics, Anhui Zhongke Gengjiu Hospital, Hefei, Anhui Province, China.
Huaqing Liu *Department of Pediatrics, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Cunxin XuDepartment of Pediatrics, Anhui Zhongke Gengjiu Hospital, Hefei, Anhui Province, China.
Feifei SongAnhui Provincial Children's Hospital, Hefei, Anhui Province, China.
Shenggang DingDepartment of Pediatrics, First Affiliated Hospital of Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Macrolide-resistant Methods: A retrospective cohort study was conducted among 71 pediatric patients with confirmed M. Results: Of the 71 isolates, 67 (94.4%) were macrolide-resistant, predominantly harboring the A2063G mutation (81.7%). The MIC₅₀/MIC₉₀ values for erythromycin and azithromycin were 126/512 μg/mL and 16/126 μg/mL, respectively. Compared with the small MSMP group ( Discussion: Macrolide resistance exceeded 94% and was mainly driven by the A2063G mutation, accompanied by high MIC values. MRMP infections were associated with prolonged clinical course and elevated inflammatory markers; however, these findings should be interpreted cautiously due to the extremely small comparator group and the descriptive nature of the analysis.

Indexed as

23S rRNA mutationsantimicrobial resistanceclinical outcomesminimal inhibitory concentrationMycoplasma pneumoniaepediatric pneumonia

Identifiers

PMID42088748
PMCPMC13136186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.